FDA Peptide Regulation and HHS Policy Holt Law Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP 1 compounding while @martymakary is photographed holding bootleg # Gray Market Peptides: So Much Hype, So Little Data BREAKING NEWS: HHS Secretary Kennedy just announced that the FDA is taking a step toward restoring science based access by removing 12 peptides from Category 2 and advancing them for formal review. FDA May Reverse Ban on 14 PeptidesWhat It Means for Your Beauty Routine Allure The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what